application, A J REPTA ET AL: "Utilization of an enantiomer as a solution to a pharmaceutical problem: Application to solubilization of 1,2-di(4-piperazine-2,6-dione)propane", JOURNAL OF PHARMACEUTICAL SCIENCES, vol.65, no.2, February 1976 (1976-02), pages 238-242, XP055130861, DOI: 10.1002/jps.260065021, A V AMELIN ET AL: "The combined use of acupuncture and antidepressants for managing the spondylogenic lumbosacral pain syndrome", FARMAKOLOGIYA I TOKSIKOLOGIYA, vol.54, no.5, 1991, pages 12-13, XP055130728, ISSN: 0014-8318, N. I. ANDREEVA ET AL: "Antidepressant-enhanced analgesic action of clonidine", PHARMACEUTICAL CHEMISTRY JOURNAL, vol.31, no.4, 1 April 1997 (1997-04-01), pages 166-167, XP055130715, ISSN: 0091-150X, DOI: 10.1007/BF02464147, WINFRIED HÄUSER ET AL: "Treatment of Fibromyalgia Syndrome With Antidepressants: A Meta-analysis", JAMA, vol.301, no.2, 14 January 2009 (2009-01-14), pages 198-209, XP055130756, ISSN: 0098-7484, DOI: 10.1001/jama.2008.944

Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/